Evidence map›Paper›PMID 42225980›Full record

ArticleNature materials2026

Fibronectin matrix remodelling modulates the active nematic dynamics of cancer-associated fibroblasts.

Cécile Jacques, Louisiane Perrin, Joseph Ackermann, Samuel Bell, Olivier Zajac, Ambre Lapierre, Lucas Anger, Clément Hallopeau, Carlos Pérez-González, Lakshmi Balasubramaniam and 5 more

Abstract read
PubMed Publisher
In one paragraph

Article in Nature materials, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Cécile Jacques *Institut Curie, PSL Research University, CNRS UMR 144, Paris, France.ORCID 0000-0002-1226-6821
Louisiane Perrin *Institut Curie, PSL Research University, CNRS UMR 144, Paris, France.ORCID 0000-0001-5691-3229
Joseph Ackermann *Laboratoire Jean Perrin, Sorbonne Université, CNRS, Paris, France.
Samuel BellLaboratoire Jean Perrin, Sorbonne Université, CNRS, Paris, France.
Olivier ZajacInstitut Curie, PSL Research University, CNRS UMR 144, Paris, France.
Ambre LapierreInstitut Curie, PSL Research University, CNRS UMR 144, Paris, France.ORCID 0009-0002-8043-2032
Lucas AngerInstitut Jacques Monod, Université Paris Cité, CNRS, Paris, France.ORCID 0009-0004-9878-1630
Clément HallopeauInstitut Curie, PSL Research University, CNRS UMR 144, Paris, France.ORCID 0000-0002-0692-2407
Carlos Pérez-GonzálezInstitut Curie, PSL Research University, CNRS UMR 144, Paris, France.
Lakshmi BalasubramaniamInstitut Jacques Monod, Université Paris Cité, CNRS, Paris, France.ORCID 0000-0001-6881-8261
Xavier TrepatInstitute for Bioengineering of Catalonia, The Barcelona Institute for Science and Technology, Barcelona, Spain.ORCID 0000-0002-7621-5214
Benoît LadouxDepartment of Physics, Friedrich-Alexander Universität Erlangen-Nürnberg, Erlangen, Germany.ORCID 0000-0003-2086-1556
Ananyo MaitraLaboratoire Jean Perrin, Sorbonne Université, CNRS, Paris, France.ORCID 0000-0003-3701-6981
Raphael VoituriezLaboratoire Jean Perrin, Sorbonne Université, CNRS, Paris, France. raphael.voituriez@sorbonne-universite.fr.ORCID 0000-0001-8746-5713
Danijela Matic VignjevicInstitut Curie, PSL Research University, CNRS UMR 144, Paris, France. danijela.matic@curie.fr.ORCID 0000-0003-4250-703X

Funding

EC | EU Framework Programme for Research and Innovation H2020 | H2020 Priority Excellent Science | H2020 European Research Council (H2020 Excellent Science - European Research Council) AdvG 883739EC | EU Framework Programme for Research and Innovation H2020 | H2020 Priority Excellent Science | H2020 European Research Council (H2020 Excellent Science - European Research Council) AvdG 101019835EC | EU Framework Programme for Research and Innovation H2020 | H2020 Priority Excellent Science | H2020 European Research Council (H2020 Excellent Science - European Research Council) CoG 772487EC | EU Framework Programme for Research and Innovation H2020 | H2020 Priority Excellent Science | H2020 European Research Council (H2020 Excellent Science - European Research Council) SyG SHAPINCELLFATELigue Contre le Cancer 2019
6 · The paper itself

Abstract

Cancer-associated fibroblasts are major architects of the tumour stroma, where their aligned, elongated morphology forms a capsule that mechanically restrains tumour expansion. However, it is unclear how this supracellular organization emerges and persists. Here we show that fibroblasts generate a fibronectin matrix that progressively acquires the same nematic order as the cell layer, and that this matrix in turn feeds back to immobilize both cells and topological defects. Using long-term live imaging, traction force microscopy, matrix microfabrication and hydrodynamic modelling, we find that this reciprocal coupling induces an ageing process in which cellular flows and defect motion slow dramatically and ultimately freeze. Despite this arrest, the monolayer remains active, with defects concentrating contractile forces that may represent mechanical weak points. Disrupting fibronectin production fluidizes the capsule, reactivates defect dynamics and compromises its barrier-like function. These findings reveal a self-organizing mechanism by which fibroblasts and their matrix co-evolve to create a mechanically stable, yet active, stromal architecture with direct implications for tumour dissemination.

Indexed as

Cancer-Associated FibroblastsExtracellular MatrixFibroblastsFibronectinsAnimalsHumansFibronectins

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.